Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (65)

2024

  1. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 1, pp. 60-72

  2. Expanding the Phenotypic Spectrum of TRAF7-Related Cardiac, Facial, and Digital Anomalies With Developmental Delay: Report of 11 New Cases and Literature Review

    Pediatric Neurology, Vol. 155, pp. 8-17

  3. Human intestinal spirochetosis: an entity associated with sexual transmitted infections

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 5, pp. 231-235

  4. Selective granulocyte–monocyte apheresis during induction with vedolizumab in moderate–severe ulcerative colitis: Experience in a tertiary hospital

    Gastroenterologia y Hepatologia

  5. Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients

    Inflammatory Bowel Diseases, Vol. 30, Núm. 2, pp. 167-182

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 10, pp. 1208-1217

  3. Current management of bowel failure due to Crohn's disease in Spain: Results of a GETECCU survey

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 6, pp. 439-445

  4. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91

  5. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  6. Influence of biologic therapy on cardiovascular risk factors in patients with inflammatory bowel disease

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 109-115

  7. Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated with Internal Fistulizing Disease: BIOSCOPE Study from GETECCU

    American Journal of Gastroenterology, Vol. 118, Núm. 6, pp. 1036-1046

  8. Randomized clinical trial evaluating three low-volume preparations for colonoscopy in outpatients with Inflammatory Bowel Disease: the EII-PREP trial

    Scandinavian Journal of Gastroenterology, Vol. 58, Núm. 6, pp. 656-663

  9. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension

    Hypertension, Vol. 80, Núm. 1, pp. 84-96

  10. Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 8, pp. 444-449

  11. Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease

    Scientific Reports, Vol. 13, Núm. 1

  12. Short stature and scoliosis: Revealing signs of ultrarare skeletal dysplasia

    Anales de Pediatria

  13. Trabectedin modulates macrophage polarization in the tumor-microenvironment. Role of KV1.3 and KV1.5 channels

    Biomedicine and Pharmacotherapy, Vol. 161

2022

  1. A genome-wide association study of survival in patients with sepsis

    Critical Care, Vol. 26, Núm. 1

  2. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss

    American Journal of Transplantation, Vol. 22, Núm. 4, pp. 1169-1181